Smith & Nephew Plc
15 April 2002
15 April 2002
NEW PRESIDENT FOR SMITH & NEPHEW ORTHOPAEDICS
Larry Papasan announces plans to retire
Smith & Nephew, the global medical device company, today announces that Larry W
Papasan, President of the company's Orthopaedic operations, plans to retire at
the end of this year. Mr Papasan, 61, will become Chairman of Smith & Nephew's
Orthopaedics Division from 1 May until his retirement and work with the new
President to ensure a smooth transition.
The new President of Smith & Nephew Orthopaedics will be Mr. David Illingworth,
48, who has wide executive experience in leading advanced medical device
companies and a strong background in global business operations, sales and
marketing.
An American, Mr Illingworth's background was initially with GE Medical Systems
in the United States and Asia, followed by senior positions in medical device
companies Nellcor Puritan Bennett and VidaMed Inc. Until recently he was
President of XL Vision Inc., a company that created technology spin-offs.
Smith & Nephew Chief Executive Chris O'Donnell said: 'Larry Papasan has made a
major contribution to the success of our orthopaedics business, steering it to
become one of the most successful in its sector.
'David Illingworth brings strategic level experience of growing companies
globally and will provide strong leadership to our continuing development as a
major orthopaedics business. David's experience will be a valuable asset in our
continuing commitment to drive our business in our key world markets through the
launch of high technology products and a strong and knowledgeable sales force.'
Enquiries:
Peter Hooley, Finance Director Tel: +44 (0) 20 7401 7646
Smith & Nephew plc
Margaret Stewart, Group Director, Corporate Affairs Tel: +44 (0) 20 7401 7646
Smith & Nephew plc
David Yates Tel: +44 (0) 20 7831 3113
Financial Dynamics
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.